Lord, Abbett & Co’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-106,905
Closed -$2.18M 711
2018
Q4
$2.18M Buy
106,905
+2,608
+3% +$81.6K 0.01% 736
2018
Q3
$3.84M Sell
104,297
-249,848
-71% -$10.9M 0.01% 769
2018
Q2
$17.8M Sell
354,145
-6,787
-2% -$299K 0.05% 501
2018
Q1
$13.2M Buy
360,932
+192,558
+114% +$5.91M 0.04% 572
2017
Q4
$4.76M Buy
+168,374
New +$3.97M 0.01% 758

Other funds holding AXGN

Lord, Abbett & Co's AXGN Position: Q1 2019 in Review

Lord, Abbett & Co sold out of Axogen (AXGN) in Q1 2019, closing a stake of 106,905 shares — an estimated $2.18M sold.

Lord, Abbett & Co first reported a position in AXGN in Q4 2017 and held it in 5 quarters. The position peaked at $17.8M in Q2 2018. 141 funds tracked by Wall St. Rank hold AXGN as of Q1 2019.

  • Lord, Abbett & Co reported no remaining Axogen position as of Q1 2019 after selling out during the quarter.
  • Lord, Abbett & Co sold 106,905 Axogen shares in Q1 2019, an estimated $2.18M.
  • Lord, Abbett & Co first reported a position in Axogen in Q4 2017 and held it in 5 quarters.
  • Lord, Abbett & Co's Axogen position peaked at $17.8M in Q2 2018.
  • 141 funds tracked by Wall St. Rank held Axogen as of Q1 2019.

Based on Lord, Abbett & Co's 13F filing for Q1 2019, filed 15 May 2019.